Jul 29, 2019
Relmada Therapeutics Announces Completion of Dosing with REL-1017 in Phase 2 Study of Individuals with Treatment Resistant Depression
Jul 29, 2019
Neuronetics® Launches TrakStar® Plus Patient Data Management System to Maximize Physician Time with Patients
Jul 23, 2019
Kalypso Wellness Center Patients See 90 Success Rates
Jul 08, 2019
NeuroStar® Patient Outcomes Registry Has Now Surpassed 3,000 Evaluable Patients, Making It The World's Largest in Major Depressive Disorder
Jun 11, 2019
Actify Neurotherapies Announces Launch of SPRAVATO(TM) Pilot Program
Jun 03, 2019
NeuroRX to Present Phase 2 Efficacy Data for NRX-101 at 2019 BIO International Convention
May 30, 2019
Lemonaid Health launches first on demand depression and anxiety online treatment service
May 30, 2019
NeuroRx Reports Phase 2 Efficacy for NRX-101, a Breakthrough Therapy Targeting Suicidal Bipolar Depression
May 28, 2019
Allergan and Gedeon Richter Receive U.S. FDA Approval For Expanded Use of VRAYLAR® (cariprazine) in the Treatment of Bipolar Depression
May 21, 2019
New Data Highlights the Value of SPRAVATO(TM) (esketamine) CIII Nasal Spray, the First New Antidepressant in Decades that Works Differently for Adults with Treatment-Resistant Depression (TRD)[1]
May 18, 2019
New Real-World Evidence Highlights Need for Interventions to Improve Outcomes for Patients Who Have Been Diagnosed with Major Depressive Disorder (MDD) and Suicide Ideation or Attempt
Apr 28, 2019
Author Jalesa Morrison Announces New Book: Four Years of Despair
Apr 18, 2019
Synergistic Therapeutics Obtains US Patent for Sublingual Ketamine Treatment for Depression
Apr 01, 2019
Houston Physicians Embrace New 3-Minute Magnetic Brain Stimulation to Combat Depression
Mar 27, 2019
Depression Discriminates In The Workplace
Mar 27, 2019
Center for Focused Care Provides Innovative and Effective Non-Drug Treatment for Depression
Mar 25, 2019
Postpartum Support International Statement on FDA Approval of First Treatment Indicated for Postpartum Depression
Mar 22, 2019
Dr. Srini Pillay, Best-Selling Author, Examines the Plight of Millennials
Mar 21, 2019
Neuronetics, Inc. Celebrates Dr. Charles Epstein's Contributions to Magnetic Stimulation Research
Mar 19, 2019
Announcing New Services and Products for Depression Treatment